Drupal.behaviors.print = function(context) {window.print();window.close();}>
Illumina to Acquire Verinata for up to $450M
January 07, 2013
Illumina to Acquire Verinata for up to $450M
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Sequenom's CEO 'Puzzled' by Illumina's Buy of Verinata, Lays out 2013 Goals at JP Morgan
January 10, 2013 / GenomeWeb Daily News
Following Verinata Acquisition, Illumina Plans to Submit Prenatal Test to FDA as IVD Product
January 9, 2013 / Clinical Sequencing News
PerkinElmer to Market Verinata's Noninvasive Prenatal Trisomy Test
January 9, 2013 / GenomeWeb Daily News
NIPT and Cancer Drive Illumina's Clinical Business in Q1 as it Looks to Launch Fetal Aneuploidy IVD
April 24, 2013 / Clinical Sequencing News
Illumina Focuses on Reproductive Health; May Modify MiSeq/HiSeq for Different Clinical Needs
January 30, 2013 / Clinical Sequencing News